5,061 results on '"epoetin alfa"'
Search Results
252. Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure
253. A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
254. A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.
255. A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
256. A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia
257. A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors
258. A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
259. A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies
260. A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
261. A Study of Mircera for the Treatment of Anemia in Dialysis Patients
262. A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
263. A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy
264. A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
265. A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
266. Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia
267. A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
268. A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
269. Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
270. A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.
271. A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.
272. Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis
273. A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
274. Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis (DIAMOND)
275. A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
276. A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia
277. A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
278. A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.
279. A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.
280. Erythropoietin in Traumatic Brain Injury (EPO-TBI) (EPO-TBI)
281. Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
282. The Clinical Evaluation of the Dose of Erythropoietins Trial (CEDOSE)
283. Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
284. An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy
285. A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
286. A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis
287. A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
288. A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
289. MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia
290. STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
291. Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant (Neo-PDGF)
292. A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.
293. A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
294. Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia
295. A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.
296. A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia
297. Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
298. MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5 (MONITOR-CKD5)
299. LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
300. Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.